These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 27264023)

  • 1. Comments on 'Test non-inferiority (and equivalence) based on the odds ratio under a simple crossover trial'.
    Lui KJ
    Stat Med; 2016 Jul; 35(16):2845-6. PubMed ID: 27264023
    [No Abstract]   [Full Text] [Related]  

  • 2. Comments on 'Likelihood ratio and score tests to test the non-inferiority (or equivalence) of the odds ratio in a crossover study with binary outcomes'.
    Lui KJ
    Stat Med; 2017 Jan; 36(1):197-198. PubMed ID: 27917554
    [No Abstract]   [Full Text] [Related]  

  • 3. Test non-inferiority (and equivalence) based on the odds ratio under a simple crossover trial.
    Lui KJ; Chang KC
    Stat Med; 2011 May; 30(11):1230-42. PubMed ID: 21538451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exact sample-size determination in testing non-inferiority under a simple crossover trial.
    Lui KJ; Chang KC
    Pharm Stat; 2012; 11(2):129-34. PubMed ID: 22232060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Likelihood ratio and score tests to test the non-inferiority (or equivalence) of the odds ratio in a crossover study with binary outcomes.
    Li X; Li H; Jin M; D Goldberg J
    Stat Med; 2016 Sep; 35(20):3471-81. PubMed ID: 27095359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comments on 'Sample size for equivalence trials: A case study from a vaccine lot consistency trial' by J. Ganju, A. Izu and A. Anemona, Statistics in Medicine 2008; 27:3743-3754.
    Kohberger RC
    Stat Med; 2009 Jan; 28(1):177-8, author reply 178-9. PubMed ID: 18937271
    [No Abstract]   [Full Text] [Related]  

  • 7. Practical guide to sample size calculations: non-inferiority and equivalence trials.
    Flight L; Julious SA
    Pharm Stat; 2016; 15(1):80-9. PubMed ID: 26604186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size determination for equivalence assessment with multiple endpoints.
    Sun A; Dong X; Tsong Y
    J Biopharm Stat; 2014; 24(6):1203-14. PubMed ID: 25032845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic equivalence: fallacies and falsification.
    Garrett AD
    Stat Med; 2003 Mar; 22(5):741-62. PubMed ID: 12587103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equivalence testing with dental clinical trials.
    Burns DR; Elswick RK
    J Dent Res; 2001 Jun; 80(6):1513-7. PubMed ID: 11499504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the use of the ratio or the odds ratio of cure rates in therapeutic equivalence clinical trials with binary endpoints.
    Tu D
    J Biopharm Stat; 1998 May; 8(2):263-82. PubMed ID: 9598422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mixed approach for proving non-inferiority in clinical trials with binary endpoints.
    Rousson V; Seifert B
    Biom J; 2008 Apr; 50(2):190-204. PubMed ID: 18311852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tests for equivalence based on odds ratio for matched-pair design.
    Liu JP; Fan HY; Ma MC
    J Biopharm Stat; 2005; 15(6):889-901. PubMed ID: 16279349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On sample size calculation based on odds ratio in clinical trials.
    Wang H; Chow SC; Li G
    J Biopharm Stat; 2002 Nov; 12(4):471-83. PubMed ID: 12477070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size considerations in active-control non-inferiority trials with binary data based on the odds ratio.
    Siqueira AL; Todd S; Whitehead A
    Stat Methods Med Res; 2015 Aug; 24(4):453-61. PubMed ID: 24492793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample sizes for clinical trials with normal data.
    Julious SA
    Stat Med; 2004 Jun; 23(12):1921-86. PubMed ID: 15195324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing individual equivalence in parallel group and crossover designs: Exact test and sample size procedures.
    Shieh G
    PLoS One; 2022; 17(5):e0269128. PubMed ID: 35622872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methodological and statistical aspects of equivalence and non inferiority trials].
    Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
    Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size determination for a three-arm equivalence trial of normally distributed responses.
    Chang YW; Tsong Y; Dong X; Zhao Z
    J Biopharm Stat; 2014; 24(6):1190-202. PubMed ID: 25098678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proving non-inferiority or equivalence of two treatments with dichotomous endpoints using exact methods.
    Chan IS
    Stat Methods Med Res; 2003 Jan; 12(1):37-58. PubMed ID: 12617507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.